Clinical Trial Update: Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update for deutetrabenazine targeting tardive dyskinesia in individuals with intellectual or developmental disabilities. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental Disabilities
• Intellectual Disability
• Tardive Dyskinesia

Drugs mentioned

• AUSTEDO (deutetrabenazine)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Tardive Dyskinesia, Intellectual Disability | Phase 4 | Status: NOT_YET_RECRUITING